Feed

Show only
Dr André E. Lebrecht, LL.M.
18/09/2018
CMS ad­vises Nov­el­is on the Ac­quis­i­tion of Rolling Busi­ness...
21 Sep 18
Bey­ond Bound­ar­ies
12/09/2018
CMS - Fo­cus­ing on Funds - Re­spons­ib­il­ity and Sus­tain­ab­il­ity Mat­ters
This Fo­cus­ing on Funds up­date looks at a de­vel­op­ing hot top­ic of sus­tain­able, re­spons­ible and im­pact in­vest­ment (SRI) and why this mat­ters for funds. En­vir­on­ment­al, so­cial and gov­ernance (ESG) and SRI is­sues have be­come an in­creas­ingly im­port­ant part of the.
Dr Pascal G. Favre
17/09/2018
Mer­ger con­trol re­view in Switzer­land
26 Sep 18
We­bin­ar: Mer­ger Con­trol and Com­pet­i­tion Law in M&A...
10/09/2018
Brexit and the in­sur­ance sec­tor – in­form cus­tom­ers about Brexit’s...
The European In­sur­ance and Oc­cu­pa­tion­al Pen­sions Au­thor­ity (“EIOPA”) provided an opin­ion on in­form­ing cus­tom­ers about the im­pact of the with­draw­al of the United King­dom from the European Uni­on (“Opin­ion”).
31/08/2018
CMS ad­vises UBS on the sale of the hotel Wid­der
22 Nov 18
CMS Glob­al Life Sci­ences & Health­care For­um
The Big Bang - Tech­no­lo­gies re­volu­tion­ising Life Sci­ences...
24/08/2018
Gov­ern­ment Is­sues Brexit Tech­nic­al No­tice for Life Sci­ences
On 23 Au­gust 2018, the UK Gov­ern­ment (the "Gov­ern­ment") is­sued the first wave of its tech­nic­al pa­pers de­signed to provide guid­ance to com­pan­ies to help pre­pare for a "No Deal" Brexit. In this scen­ario, there will be no "trans­ition peri­od" but rather the UK.